2020
DOI: 10.1055/s-0040-1709207
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Strategies for Tandem Occlusions in Acute Ischemic Stroke

Abstract: There is no consensus for the treatment of a tandem occlusion (TO) in a patient presenting with an acute ischemic stroke. In this review article, we will focus on the controversial treatment strategies for TOs. First, we will discuss treatment options including retrograde, antegrade, and delayed approaches. Second, the role of carotid stent placement versus balloon angioplasty for the extracranial occlusion will be presented. Third, anticoagulation and antiplatelet regimens for the treatment TOs published in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 52 publications
0
5
0
Order By: Relevance
“…The current 2019 AHA/ASA guidelines on endovascular treatment of TO recommend EVT with recanalization of both extracranial and intracranial occlusions (class IIb, level B-R) [ 8 ]. However, the technical approach, timing in the treatment of cICA and medical management are still unsettled [ 8 , 9 ]. More information is needed to increase the chances of better outcome and reduce serious adverse events such as symptomatic intracranial hemorrhage (sICH), embolization in new territories and stent thrombosis.…”
Section: Introductionmentioning
confidence: 99%
“…The current 2019 AHA/ASA guidelines on endovascular treatment of TO recommend EVT with recanalization of both extracranial and intracranial occlusions (class IIb, level B-R) [ 8 ]. However, the technical approach, timing in the treatment of cICA and medical management are still unsettled [ 8 , 9 ]. More information is needed to increase the chances of better outcome and reduce serious adverse events such as symptomatic intracranial hemorrhage (sICH), embolization in new territories and stent thrombosis.…”
Section: Introductionmentioning
confidence: 99%
“…[17][18][19] It has been well known that there are several theoretic advantages of anterograde technology, including increase in distal perfusion from collaterals following improvement in proximal flow, decrease in risk of vessel dissection or perforation by nonblind navigation of the ICA, and better accessibility of intracranial lesions for effective treatment with thrombectomy device. 20 However, disadvantages of this technique include the distal migration of the intracranial thrombus provoked by re-established anterograde carotid flow, potential snagging of the retrievable stent in the struts of an already-deployed extracranial ICA stent, and potential hemodynamic instability due to baroreceptor activation. 14,[20][21][22][23] The advantage to retrograde stent approach is a shorter intracranial recanalization time while avoiding the disadvantages of anterograde technology, but this is only if the cervical ICA lesion can be crossed.…”
Section: Introductionmentioning
confidence: 99%
“…20 However, disadvantages of this technique include the distal migration of the intracranial thrombus provoked by re-established anterograde carotid flow, potential snagging of the retrievable stent in the struts of an already-deployed extracranial ICA stent, and potential hemodynamic instability due to baroreceptor activation. 14,[20][21][22][23] The advantage to retrograde stent approach is a shorter intracranial recanalization time while avoiding the disadvantages of anterograde technology, but this is only if the cervical ICA lesion can be crossed. 14,[20][21][22][23] Thus, the strategy of passing the extracranial ICA lesion is the key process but has not been well resolved in retrograde approach.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The current 2019 AHA/ASA guidelines on endovascular treatment of TO recommend EVT with recanalization of both extracranial and intracranial occlusions (class IIb, level B-R) [8]. However, the technical approach, timing in the treatment of cICA and medical management are still unsettled [8,9]. More information is needed to increase the chances of better outcome and reduce serious adverse events such as symptomatic intracranial hemorrhage (sICH), embolization in new territories and stent reocclusions.…”
mentioning
confidence: 99%